While CRISPR gene-editing technology holds immense theoretical potential for targeting age-related cellular degeneration and extending healthspan, completely reversing the complex biological aging process in humans remains an experimental frontier. Researchers are actively investigating how targeted genetic interventions can clear senescent cells and repair DNA damage, but turning these laboratory models into safe anti-aging human therapies will require decades of extensive clinical trials.